|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
00570 TRAD CHI MED
Nominal 
1.335 0.000 (0.000%) | 2026/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2025/12 RMB(K¥) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | |
| Turnover | 5,438,498 | -27.131% | 14,744,779 | 16,509,708 | 18,121,861 | 14,304,242 |
| Cost of Sales | (2,857,654) | -25.364% | (7,653,651) | (8,653,400) | (8,847,369) | (7,105,790) |
| Gross Profit | 2,580,844 | -28.992% | 7,091,128 | 7,856,308 | 9,274,492 | 7,198,452 |
| 2026/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2025/12 RMB(K¥) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | (139,185) | -25.119% | (212,566) | (106,554) | (9,366) | (10,073) | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | -- | |
| Other Non-operating Items | -- | -- | -- | -- | -- | -- | |
| Share of Results of Asso. & JCEs | (57) | 21.277% | (197) | (950) | (3,699) | (3,479) | |
| Profit / (Loss) before Taxation | (759,927) | 816.248% | (368,229) | 163,109 | 1,224,533 | 840,109 | |
| Taxation | (74,768) | 27.111% | (89,860) | (142,338) | 171,537 | (119,144) | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | 58,398 | 72.561% | 116,019 | 33,296 | (110,870) | 43,521 | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | (776,297) | 619.340% | (342,070) | 54,067 | 1,285,200 | 764,486 | |
| 2026/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2025/12 RMB(K¥) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | |
| Net Finance Costs / (Income) | 19,960 | -31.884% | 64,476 | 123,858 | 133,788 | 153,426 |
| Depreciation & Amortisation | 572,885 | -0.753% | 1,158,866 | 1,130,224 | 1,133,271 | 1,099,397 |
| Directors' Emoluments | -- | -- | 3,767 | 4,402 | 8,932 | 8,971 |
| 2026/06 - Interim | %Chg (Compare to Interim) | 2025/12 | 2024/12 | 2023/12 | 2022/12 | |
| Auditor's Opinion Status | N/A | -- | Unqualified | Unqualified | Unqualified | Unqualified |
Market Valuation Indicators
| 2026/06 - Interim | %Chg (Compare to Interim) | 2025/12 | 2024/12 | 2023/12 | 2022/12 | |
| EPS (cts) | -15.420 | 620.561% | -6.790 | 1.070 | 25.520 | 15.180 |
| DPS (cts) | 0.000 | -- | 0.000 | 7.980 | 0.000 | 4.550 |
| Dividend Payout Ratio (%) | -- | -- | -- | 745.794% | -- | 29.974% |
| Cash flow per share ($) | -- | -- | 0.453 | 0.513 | 0.232 | 0.217 |
| NBV per share ($) | 3.911 | -- | 4.065 | 4.211 | 4.202 | 4.005 |
| Remarks: | Real time quote last updated: 08/09/2026 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB -776,297 |
| %Change | 619.340% |
| EPS / (LPS) | RMB -0.154 |
| NBV Per Share (¥) | RMB 3.911 |